Crestline Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,061	Closed	-$510K	–	249
2021 Q3	$510K	Hold	5,061	–	–	0.05%	147
2021 Q2	$505K	Buy	+5,061	New	+$505K	0.04%	113